Andrew (Andy) Smith



"We help fuel companies that are accelerating change and improving lives, which is pretty amazing. I love being part of that growth and purpose at Oak HC/FT."

Active Investments

  • August Bioservices
  • Curana Health
  • DispatchHealth
  • Infusion for Health
  • Komodo Health
  • Maven
  • Modern Age
  • Precision for Medicine
  • Rubicon Founders
  • Truepill
  • WithMe Health

Prior Investments

  • Olive

Andy Smith (HC), a Principal at Oak HC/FT, joined the firm in 2017 and focuses on growth equity and early-stage venture opportunities in Healthcare.

Andy currently serves as a Board Observer at August Bioservices, Curana Health, Infusion for Health, Maven and Truepill. Andy is also actively involved with DispatchHealth, Komodo Health, Modern Age, Precision for Medicine, Rubicon Founders and WithMe Health. His prior investments include Olive.

Prior to joining Oak HC/FT, Andy was an Associate at Safeguard Scientifics where he focused on technology-driven businesses in healthcare. Prior to this, Andy was an Analyst at Credit Suisse where he focused on the healthcare services sector.

Andy received a Bachelor of Science degree from the University of Virginia’s McIntire School of Commerce.


Dream Vacation?

A week on Mars.

The first thing you do every morning is…

Locate the closest cold brew.

What book have you read again and again?

Dune by Frank Herbert

Favorite app?


Favorite board game?

Settlers of Catan